Home | Dendrogenix

Dendrogenix
Dendrogenins

ATTENTION: The file https://www.dendrogenix.com/embeds/banner-02.md does not exist.

Header

DISCOVER NOW
Dendrogenix

ATTENTION: The file https://www.dendrogenix.com/embeds/banner-03.md does not exist.
Dendrogenix

ATTENTION: The file https://www.dendrogenix.com/embeds/banner-03.md does not exist.

COMPANY

Established in 2018, Dendrogenix is a Belgian biopharmaceutical company based in Liège.

Dendrogenix is specialized in the development of innovative drugs called Dendrogenins, which are small molecules with high therapeutic potential.

Dendrogenix is dedicated to the preclinical and clinical development of Dendrogenins, mainly in the field of neuronal dysfunction.

Dendrogenix focuses primarily on the area of auditory degeneration for which there are no approved drugs yet.

More

TECHNOLOGY

Dendrogenix has developed international research partnerships with leading players in the field of deafness and neurology, including world-renowned academic centers such as the GIGA-Neurosciences at the University of Liège, and the University of Tübingen in Germany.

More

TEAM

Dendrogenix currently employs around 20 people, including doctors in chemistry and biology as well as consultants who are experts in preclinical and clinical pharmaceutical regulatory development.

More